Dr. Christopher Dolan, M.D.
Micrographic Dermatologic Surgery (mds)
20+
Years in Practice
Practice Locations
1 location
About Dr. Christopher Dolan
Christopher Dolan, M.D. is a healthcare provider practicing in Bethesda, MD.
Specialty Definition
The highly-trained surgeons that perform Mohs Micrographic Surgery are specialists both in dermatology and pathology. With their extensive knowledge of the skin and unique pathological skills, they are able to remove only diseased tissue, preserving healthy tissue and minimizing the cosmetic impact of the surgery. Mohs surgeons who belong to the American College of Mohs Surgery (ACMS) have completed a minimum of one year of fellowship training at one of the ACMS-approved training centers in the U.S.
27
Years Experience
1
Location
2
States Licensed
Credentials & Board Certifications
Additional Specialties
Primary Specialty
Micrographic Dermatologic Surgery (mds)Credentials verified via NPI Registry (NPPES)
Education & Training
Medical School
Georgetown University School Of Medicine
Class of 1999
Licenses & Practice States
Licensed in 2 states
| State | License | Classification | Primary |
|---|---|---|---|
| Indiana | 01053651A | Dermatology | — |
| Maryland | D | Dermatology | — |
| Maryland | D0071005 | Dermatology | — |
| Indiana | 01053651A | Dermatology | — |
| Maryland | D0071005 | Dermatology |
Public Data Summary for Dr. Christopher Dolan
With 20 years of practice, Dr. Christopher Dolan is an established micrographic dermatologic surgery (mds) provider, M.D., after earning their medical degree at Georgetown University School Of Medicine in 1999. Dr. currently practices at Walter Reed National Military Med Cen in Bethesda, Maryland. Their National Provider Identifier (NPI) is 1497717532, and the profile below combines data from CMS NPPES, Medicare billing records, the HHS OIG exclusion list, and — where available — CMS Open Payments, Medicare Utilization, and Part D prescriber summaries.
CMS Medicare data shows Dr. Christopher Dolan as a moderate-volume micrographic dermatologic surgery (mds) provider, treating approximately 998 Medicare beneficiaries and delivering 3K services in the most recent reporting year. That panel size indicates balanced experience across typical Medicare conditions.
Under the Physician Payments Sunshine Act, CMS reports that Dr. Christopher Dolan received $58 in industry payments in 2023. Payments at this scale are typical for most practicing physicians and generally reflect routine educational activities.
Transparency & Safety
Public records from CMS and OIG databases
Industry Payments
$58
Total payments received from pharmaceutical and medical device companies in 2023.
Source: CMS Open Payments (Sunshine Act)
Opioid Prescribing
This provider has no opioid prescriptions on file in Medicare Part D data.
Insurance & Accessibility
Reviews
Community reviews for Dr. Christopher Dolan
--
0 reviews
Micrographic Dermatologic Surgery (mds) Providers Nearby
Same primary specialty near ZIP 20889
FAQ
Frequently asked questions about Dr. Christopher Dolan
What does Dr. Christopher Dolan specialize in?
Dr. Christopher Dolan specializes in Micrographic Dermatologic Surgery (mds). Secondary taxonomy filings also list Dermatology.
Where does Dr. Christopher Dolan practice?
Dr. Christopher Dolan practices at Walter Reed National Military Med Cen in Bethesda, Maryland.
Does Dr. Christopher Dolan accept Medicare?
CMS records show that Dr. Christopher Dolan accepts Medicare assignment. CMS billing data shows 998 Medicare beneficiaries treated in the most recent reporting year.
What is Dr. Christopher Dolan's NPI number?
Dr. Christopher Dolan's National Provider Identifier (NPI) is 1497717532. This is the unique 10-digit number the Centers for Medicare & Medicaid Services assigns to every practicing US healthcare provider. You can verify this number directly at the NPPES NPI Registry.
How long has Dr. Christopher Dolan been practicing?
Dr. Christopher Dolan has approximately 20 years of practice experience, having graduated from Georgetown University School Of Medicine in 1999.